| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |